BTS
CELG

BB&T Securities’s Celgene Corp CELG Stock Holding History

BB&T Securities’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3M Sell
30,207
-2,863
-9% -$272K 0.03% 483
2019
Q2 		$3.06M Sell
33,070
-17,556
-35% -$1.67M 0.03% 482
2019
Q1 		$4.78M Sell
50,626
-14,162
-22% -$1.24M 0.05% 390
2018
Q4 		$4.15M Sell
64,788
-10,729
-14% -$792K 0.05% 391
2018
Q3 		$6.76M Sell
75,517
-13,506
-15% -$1.19M 0.07% 347
2018
Q2 		$7.07M Buy
89,023
+23,889
+37% +$1.98M 0.08% 329
2018
Q1 		$5.81M Buy
65,134
+12,770
+24% +$1.23M 0.07% 347
2017
Q4 		$5.46M Buy
52,364
+12,106
+30% +$1.37M 0.07% 321
2017
Q3 		$5.87M Buy
40,258
+5,681
+16% +$774K 0.08% 311
2017
Q2 		$4.49M Buy
34,577
+7,991
+30% +$979K 0.07% 342
2017
Q1 		$3.31M Buy
26,586
+1,320
+5% +$158K 0.05% 370
2016
Q4 		$2.64M Hold
25,266
– – 0.04% 375
2016
Q3 		$2.64M Buy
25,266
+1,115
+5% +$121K 0.04% 373
2016
Q2 		$2.38M Sell
24,151
-1,660
-6% -$172K 0.04% 389
2016
Q1 		$2.58M Buy
25,811
+6,039
+31% +$622K 0.04% 344
2015
Q4 		$2.37M Buy
19,772
+2,790
+16% +$323K 0.05% 307
2015
Q3 		$1.84M Buy
16,982
+5,884
+53% +$730K 0.04% 361
2015
Q2 		$1.28M Buy
11,098
+2,887
+35% +$330K 0.03% 466
2015
Q1 		$947K Buy
8,211
+66
+0.8% +$7.89K 0.02% 534
2014
Q4 		$911K Buy
8,145
+1,447
+22% +$153K 0.02% 529
2014
Q3 		$635K Sell
6,698
-649
-9% -$58.6K 0.01% 601
2014
Q2 		$631K Buy
7,347
+541
+8% +$41.1K 0.02% 605
2014
Q1 		$475K Buy
6,806
+1,510
+29% +$120K 0.01% 611
2013
Q4 		$447K Buy
5,296
+1,208
+30% +$95.6K 0.01% 595
2013
Q3 		$315K Buy
+4,088
New +$286K 0.01% 650

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BB&T Securities's CELG Position: Q3 2019 in Review

BB&T Securities reduced its Celgene Corp (CELG) stake by 8.7% in Q3 2019, selling an estimated $272K and leaving 30,207 shares worth $3M. The position accounts for 0.03% of the portfolio, ranked #483.

BB&T Securities first reported a position in CELG in Q3 2013 and has held it in 25 quarters since. The position peaked at $7.07M in Q2 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • BB&T Securities held 30,207 shares of Celgene Corp worth $3M as of Q3 2019.
  • BB&T Securities sold 2,863 Celgene Corp shares in Q3 2019, an estimated $272K.
  • Celgene Corp made up 0.03% of BB&T Securities's portfolio in Q3 2019, its #483 holding.
  • BB&T Securities first reported a position in Celgene Corp in Q3 2013 and has held it in 25 quarters since.
  • BB&T Securities's Celgene Corp position peaked at $7.07M in Q2 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.